$CVV
CVD EQUIPMENT CORP Stock $cvv

$cvv Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000149315224031585 Filed on August 13, 2024

Income Statement

Concept	2024 Q3	2024 Q2
Revenue	$8.194M	$6.345M
YoY Change	31.44%	25.17%
Cost Of Revenue	$6.359M	$4.736M
YoY Change	37.17%	28.66%
Gross Profit	$1.835M	$1.609M
YoY Change	14.83%	15.92%
Gross Profit Margin	22.39%	25.36%
Selling, General & Admin	$1.739M	$1.842M
YoY Change	-7.7%	3.02%
% of Gross Profit	94.77%	114.48%
Research & Development	$644.0K	$665.0K
YoY Change	-8.52%	18.96%
% of Gross Profit	35.1%	41.33%
Depreciation & Amortization	$169.0K	$154.0K
YoY Change	5.62%	-31.86%
% of Gross Profit	9.21%	9.57%
Operating Expenses	$1.758M	$2.507M
YoY Change	-32.07%	-4.31%
Operating Profit	$77.00K	-$898.0K
YoY Change	-107.78%	-27.11%
Interest Expense	$131.0K	$141.0K
YoY Change	2083.33%	2250.0%
% of Operating Profit	170.13%
Other Income/Expense, Net	$131.0K	$137.0K
YoY Change	-44.73%	953.85%
Pretax Income	$208.0K	-$761.0K
YoY Change	-127.62%	-31.01%
Income Tax	$5.000K
% Of Pretax Income	2.4%
Net Earnings	$203.0K	-$761.0K
YoY Change	-126.96%	-31.63%
Net Earnings / Revenue	2.48%	-11.99%
Basic Earnings Per Share	$0.03	-$0.11
Diluted Earnings Per Share	$0.03	-$0.11
COMMON SHARES
Basic Shares Outstanding	6.882M shares	6.825M shares
Diluted Shares Outstanding	6.835M shares	6.817M shares

Balance Sheet

Concept	2024 Q3	2024 Q2
SHORT-TERM ASSETS
Cash & Short-Term Investments	$10.01M	$10.03M
YoY Change	-29.99%
Cash & Equivalents	$10.00M	$10.00M
Short-Term Investments
Other Short-Term Assets	$892.0K	$592.0K
YoY Change	5.19%	9.02%
Inventory	$2.558M	$4.658M
Prepaid Expenses
Receivables	$5.124M	$4.951M
Other Receivables	$0.00	$0.00
Total Short-Term Assets	$19.93M	$21.79M
YoY Change	-19.98%	-10.57%
LONG-TERM ASSETS
Property, Plant & Equipment	$11.91M	$12.04M
YoY Change	-2.44%	-2.11%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$10.00K	$18.00K
YoY Change	0.0%	80.0%
Total Long-Term Assets	$11.92M	$12.06M
YoY Change	-3.29%	-2.91%
TOTAL ASSETS
Total Short-Term Assets	$19.93M	$21.79M
Total Long-Term Assets	$11.92M	$12.06M
Total Assets	$31.85M	$33.85M
YoY Change	-14.45%	-7.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$1.393M	$1.601M
YoY Change	-5.69%	22.49%
Accrued Expenses	$1.903M	$1.736M
YoY Change	11.22%	4.14%
Deferred Revenue	$3.288M	$5.098M
YoY Change	-32.32%	8.42%
Short-Term Debt	$0.00	$0.00
YoY Change
Long-Term Debt Due	$85.00K	$84.00K
YoY Change	6.25%	5.0%
Total Short-Term Liabilities	$6.669M	$9.116M
YoY Change	-23.55%	17.55%
LONG-TERM LIABILITIES
Long-Term Debt	$203.0K	$225.0K
YoY Change	-29.51%	-27.18%
Other Long-Term Liabilities
YoY Change
Total Long-Term Liabilities	$203.0K	$225.0K
YoY Change	-29.51%	-27.18%
TOTAL LIABILITIES
Total Short-Term Liabilities	$6.669M	$9.116M
Total Long-Term Liabilities	$203.0K	$225.0K
Total Liabilities	$6.872M	$9.341M
YoY Change	-23.74%	15.84%
SHAREHOLDERS EQUITY
Retained Earnings	-$4.590M	-$4.793M
YoY Change	1504.9%	-1126.34%
Common Stock	$29.56M	$29.30M
YoY Change	3.73%	3.7%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$24.97M	$24.50M
YoY Change
Total Liabilities & Shareholders Equity	$31.85M	$33.85M
YoY Change	-14.45%	-7.99%

Cashflow Statement

Concept	2024 Q3	2024 Q2
OPERATING ACTIVITIES
Net Income	$203.0K	-$761.0K
YoY Change	-126.96%	-31.63%
Depreciation, Depletion And Amortization	$169.0K	$154.0K
YoY Change	5.62%	-31.86%
Cash From Operating Activities	$32.00K	-$1.729M
YoY Change	-95.73%	-170.89%
INVESTING ACTIVITIES
Capital Expenditures	$37.00K	$112.0K
YoY Change	-53.75%	43.59%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$37.00K	-$112.0K
YoY Change	-107.12%	-71.36%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	-21.00K	-21.00K
YoY Change	5.0%	31.25%
NET CHANGE
Cash From Operating Activities	32.00K	-1.729M
Cash From Investing Activities	-37.00K	-112.0K
Cash From Financing Activities	-21.00K	-21.00K
Net Change In Cash	-26.00K	-1.862M
YoY Change	-102.08%	-191.63%
FREE CASH FLOW
Cash From Operating Activities	$32.00K	-$1.729M
Capital Expenditures	$37.00K	$112.0K
Free Cash Flow	-$5.000K	-$1.841M
YoY Change	-100.75%	-177.98%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
	dei	Amendment Flag AmendmentFlag	false
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	dei	Document Transition Report DocumentTransitionReport	false
	dei	Entity File Number EntityFileNumber	1-16525
	dei	Entity Address State Or Province EntityAddressStateOrProvince	NY
	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	11722
	dei	City Area Code CityAreaCode	(631)
	dei	Local Phone Number LocalPhoneNumber	981-7081
	dei	Security12b Title Security12bTitle	Common Stock
	dei	Trading Symbol TradingSymbol	CVV
	dei	Security Exchange Name SecurityExchangeName	NASDAQ
	dei	Document Type DocumentType	10-Q
	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
	dei	Entity Filer Category EntityFilerCategory	Non-accelerated Filer
	dei	Entity Small Business EntitySmallBusiness	true
	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	6881838	shares
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13764000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1765000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4908000	usd
CY2023Q4	CVV	Deposits From Purchaser Of Mesoscribe Assets DepositsFromPurchaserOfMesoscribeAssets	597000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8554000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	268000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8822000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6825338	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6825338	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6824511	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6824511	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	68000	usd
	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q2
	dei	Entity Central Index Key EntityCentralIndexKey	0000766792
CY2024Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
CY2024Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
CY2024Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax		usd
CY2024Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit		usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness		usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges		usd
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation		usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised		usd
CY2024Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
CY2023Q2	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements		shares
	dei	Document Quarterly Report DocumentQuarterlyReport	true
	dei	Document Period End Date DocumentPeriodEndDate	2024-06-30
	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2024
	dei	Entity Registrant Name EntityRegistrantName	CVD EQUIPMENT CORPORATION
	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	NY
	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	11-2621692
	dei	Entity Address Address Line1 EntityAddressAddressLine1	355 South Technology Drive
	dei	Entity Address City Or Town EntityAddressCityOrTown	Central Islip
	dei	Entity Listing Par Value Per Share EntityListingParValuePerShare	0.01
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14025000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	1906000	usd
CY2023Q4	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1604000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4454000	usd
CY2023Q4	us-gaap	Other Assets Current OtherAssetsCurrent	852000	usd
CY2023Q4	us-gaap	Assets Current AssetsCurrent	22841000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	12166000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	18000	usd
CY2023Q4	us-gaap	Assets Assets	35025000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	1203000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	1765000	usd
CY2023Q4	us-gaap	Long Term Debt Current LongTermDebtCurrent	81000	usd
CY2023Q4	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	4908000	usd
CY2024Q2	CVV	Deposits From Purchaser Of Mesoscribe Assets DepositsFromPurchaserOfMesoscribeAssets	597000	usd
CY2023Q4	CVV	Deposits From Purchaser Of Mesoscribe Assets DepositsFromPurchaserOfMesoscribeAssets	597000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	8554000	usd
CY2023Q4	us-gaap	Long Term Debt Noncurrent LongTermDebtNoncurrent	268000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	8822000	usd
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.01
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	20000000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6825338	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6825338	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	6824511	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	6824511	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	68000	usd
CY2024Q2	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	29229000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28695000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2560000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26203000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9943000	usd
	us-gaap	Gross Profit GrossProfit	3821000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1161000	usd
	us-gaap	Selling Expense SellingExpense	847000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2960000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
CY2023Q2	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2620000	usd
	us-gaap	Operating Expenses OperatingExpenses	4994000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-898000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1232000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2526000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1420000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	145000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	28695000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-4793000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-2560000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	24504000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26203000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	33845000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	35025000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6345000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5069000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	8799000	usd
	us-gaap	Cost Of Revenue CostOfRevenue	9943000	usd
CY2023Q2	us-gaap	Gross Profit GrossProfit	1388000	usd
	us-gaap	Gross Profit GrossProfit	2468000	usd
	us-gaap	Gross Profit GrossProfit	3821000	usd
CY2024Q2	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	665000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1410000	usd
	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	1161000	usd
CY2024Q2	us-gaap	Selling Expense SellingExpense	426000	usd
CY2023Q2	us-gaap	Selling Expense SellingExpense	428000	usd
	us-gaap	Selling Expense SellingExpense	845000	usd
	us-gaap	Selling Expense SellingExpense	847000	usd
CY2024Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1416000	usd
CY2023Q2	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	1360000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2739000	usd
	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	2960000	usd
CY2023Q2	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
CY2024Q2	us-gaap	Operating Expenses OperatingExpenses	2507000	usd
CY2023Q2	us-gaap	Operating Expenses OperatingExpenses	2620000	usd
	us-gaap	Operating Expenses OperatingExpenses	4994000	usd
	us-gaap	Operating Expenses OperatingExpenses	5241000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-898000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1232000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2526000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1420000	usd
CY2024Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	145000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	107000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	302000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	227000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	10000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	43000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	20000	usd
CY2023Q2	us-gaap	Investment Income Interest InvestmentIncomeInterest	107000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	302000	usd
	us-gaap	Investment Income Interest InvestmentIncomeInterest	227000	usd
CY2024Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	4000	usd
CY2023Q2	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	6000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	10000	usd
	us-gaap	Interest Expense Nonoperating InterestExpenseNonoperating	12000	usd
CY2023Q2	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	15000	usd
	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	43000	usd
CY2024Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-4000	usd
CY2023Q2	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	13000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	1000	usd
	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	20000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	137000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	129000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	293000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	278000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-761000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1103000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2233000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1142000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-761000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2233000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1153000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6778754	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6813127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6776035	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6816956	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6813127	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6776035	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	24998000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-761000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	267000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	24504000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	29567000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	262000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26203000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2233000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	534000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	24504000	usd
CY2024Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	137000	usd
CY2023Q2	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	129000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	293000	usd
	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	278000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-761000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1103000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2233000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1142000	usd
CY2023Q2	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	10000	usd
	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	11000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-761000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1153000	usd
CY2024Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.11
CY2023Q2	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.16
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.33
	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.17
CY2024Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.11
CY2023Q2	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.16
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.33
	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.17
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6778754	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6813127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6776035	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6778754	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6813127	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6776035	shares
CY2024Q1	us-gaap	Stockholders Equity StockholdersEquity	24998000	usd
CY2024Q2	us-gaap	Net Income Loss NetIncomeLoss	-761000	usd
CY2024Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	267000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	24504000	usd
CY2023Q1	us-gaap	Stockholders Equity StockholdersEquity	29567000	usd
CY2023Q2	us-gaap	Net Income Loss NetIncomeLoss	-1113000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	262000	usd
CY2023Q2	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	3000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	26203000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2233000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	534000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	24504000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29399000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29399000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1153000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	397000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	76000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2233000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1153000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	534000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	397000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29399000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	29399000	usd
	us-gaap	Stock Issued During Period Value Share Based Compensation StockIssuedDuringPeriodValueShareBasedCompensation	397000	usd
	us-gaap	Stock Issued During Period Value Stock Options Exercised StockIssuedDuringPeriodValueStockOptionsExercised	76000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	28719000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-2233000	usd
	us-gaap	Net Income Loss NetIncomeLoss	-1153000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	534000	usd
	us-gaap	Share Based Compensation ShareBasedCompensation	397000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	307000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	392000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1592000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-50000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	781000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	204000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1616000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-260000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-231000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	398000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-57000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-29000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-770000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	190000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	659000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-833000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	182000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	225000	usd
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	312000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-182000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-537000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	40000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	38000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	76000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3994000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1332000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14025000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14365000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10031000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13033000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10000	usd
	us-gaap	Interest Paid Net InterestPaidNet	12000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10000000.0	usd
CY2024Q2	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	307000	usd
	us-gaap	Gain Loss On Sale Of Business GainLossOnSaleOfBusiness	-162000	usd
	us-gaap	Asset Impairment Charges AssetImpairmentCharges	111000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	3045000	usd
	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-1592000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	-50000	usd
	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	781000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	204000	usd
	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	1616000	usd
	us-gaap	Increase Decrease In Other Current Assets IncreaseDecreaseInOtherCurrentAssets	-231000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	398000	usd
	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-57000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-29000	usd
	us-gaap	Increase Decrease In Accrued Liabilities IncreaseDecreaseInAccruedLiabilities	-770000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	190000	usd
	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	659000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3772000	usd
	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-833000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	182000	usd
	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	225000	usd
	us-gaap	Cash Divested From Deconsolidation CashDivestedFromDeconsolidation	312000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-182000	usd
	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-537000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	40000	usd
	us-gaap	Repayments Of Long Term Debt RepaymentsOfLongTermDebt	38000	usd
	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	76000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-40000	usd
	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	38000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-3994000	usd
	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	-1332000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14025000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	14365000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	10031000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Including Disposal Group And Discontinued Operations CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations	13033000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	3000	usd
	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	11000	usd
	us-gaap	Interest Paid Net InterestPaidNet	10000	usd
	us-gaap	Interest Paid Net InterestPaidNet	12000	usd
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10000000.0	usd
CY2024Q2	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
CY2023Q2	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Capitalized Contract Cost Impairment Loss CapitalizedContractCostImpairmentLoss	0	usd
	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance or fifteen months from the date of shipment by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of revenue” in the condensed consolidated statements of operations. The estimated warranty cost is based on the Company’s historical cost. The Company updates its warranty estimates based on actual costs incurred.
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10000000.0	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	100000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1500000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6345000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	5069000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11267000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13764000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	21600000	usd
CY2024Q2	CVV	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	11009000	usd
	us-gaap	Standard Product Warranty Description StandardProductWarrantyDescription	The Company typically provides standard warranty coverage on its systems for one year from the date of final acceptance or fifteen months from the date of shipment by providing labor and parts necessary to repair the systems during the warranty period. The Company records the estimated warranty cost when revenue is recognized on the related system. Warranty cost is included in “Cost of revenue” in the condensed consolidated statements of operations. The estimated warranty cost is based on the Company’s historical cost. The Company updates its warranty estimates based on actual costs incurred.
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	10000000.0	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	14000000.0	usd
CY2024Q2	us-gaap	Cash Uninsured Amount CashUninsuredAmount	100000	usd
CY2023Q4	us-gaap	Cash Uninsured Amount CashUninsuredAmount	1500000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable Current AllowanceForDoubtfulAccountsReceivableCurrent	36000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	6345000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	11267000	usd
	us-gaap	Revenue From Contract With Customer Including Assessed Tax RevenueFromContractWithCustomerIncludingAssessedTax	13764000	usd
CY2024Q2	us-gaap	Revenue Remaining Performance Obligation RevenueRemainingPerformanceObligation	21600000	usd
CY2024Q2	CVV	Costs Incurred On Uncompleted Contracts CostsIncurredOnUncompletedContracts	11009000	usd
CY2024Q2	CVV	Estimated Earnings EstimatedEarnings	5609000	usd
CY2024Q2	CVV	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	16618000	usd
CY2024Q2	CVV	Billings To Date BillingsToDate	19589000	usd
CY2024Q2	CVV	Estimated Earnings EstimatedEarnings	5609000	usd
CY2024Q2	CVV	Costs And Estimated Earnings On Uncompleted Contracts CostsAndEstimatedEarningsOnUncompletedContracts	16618000	usd
CY2024Q2	CVV	Billings To Date BillingsToDate	19589000	usd
CY2024Q2	CVV	Net Cost In Excess Of Billings NetCostInExcessOfBillings	-2971000	usd
CY2024Q2	CVV	Deferred Revenues Related To Contracts DeferredRevenuesRelatedToContracts	-573000	usd
CY2024Q2	CVV	Contract Liability In Excess Of Contract Assets ContractLiabilityInExcessOfContractAssets	-3544000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1554000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5098000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4600000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2600000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2231000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1612000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1248000	usd
CY2024Q2	us-gaap	Inventory Finished Goods InventoryFinishedGoods	815000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	855000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	4658000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4454000	usd
CY2024Q2	CVV	Net Cost In Excess Of Billings NetCostInExcessOfBillings	-2971000	usd
CY2024Q2	CVV	Deferred Revenues Related To Contracts DeferredRevenuesRelatedToContracts	-573000	usd
CY2024Q2	CVV	Contract Liability In Excess Of Contract Assets ContractLiabilityInExcessOfContractAssets	-3544000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net Current ContractWithCustomerAssetNetCurrent	1554000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	5098000	usd
CY2023	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4600000	usd
CY2022	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	4100000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2700000	usd
	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	2600000	usd
CY2024Q2	us-gaap	Inventory Raw Materials InventoryRawMaterials	2231000	usd
CY2023Q4	us-gaap	Inventory Raw Materials InventoryRawMaterials	2351000	usd
CY2024Q2	us-gaap	Inventory Work In Process InventoryWorkInProcess	1612000	usd
CY2023Q4	us-gaap	Inventory Work In Process InventoryWorkInProcess	1248000	usd
CY2023Q4	us-gaap	Inventory Finished Goods InventoryFinishedGoods	855000	usd
CY2023Q4	us-gaap	Inventory Net InventoryNet	4454000	usd
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6778754	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6813127	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6778754	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6813127	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6776035	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	838125	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	416875	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	599500	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	297500	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	267000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	262000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	534000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	397000	usd
CY2024Q2	us-gaap	Share Price SharePrice	4.75
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.75
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.77	pure
CY2024Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6778754	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6813127	shares
	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	6776035	shares
CY2024Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6816956	shares
CY2023Q2	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6778754	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6813127	shares
	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	6776035	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	838125	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	416875	shares
CY2023Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	297500	shares
CY2024Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	267000	usd
CY2023Q2	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	262000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	534000	usd
	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	397000	usd
CY2024Q2	us-gaap	Share Price SharePrice	4.75
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExercisePrice	4.75
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate	0.77	pure
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate	0.0412	pure
	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1	P6Y
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	846875	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.75
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	13750	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.94
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	838125	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.18
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q2	us-gaap	Assets Assets	33845000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6345000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-898000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-761000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154000	usd
CY2024Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	105000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5069000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1232000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1103000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	227000	usd
CY2023Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	78000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11267000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2526000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2233000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	307000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	182000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	13764000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-1420000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1142000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	392000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	846875	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.20
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross	5000	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	4.75
	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod	13750	shares
	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice	7.94
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	838125	shares
CY2024Q2	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	8.18
	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	3	segment
CY2024Q2	us-gaap	Assets Assets	33845000	usd
CY2024Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	6345000	usd
CY2024Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-898000	usd
CY2024Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-761000	usd
CY2024Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	154000	usd
CY2024Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	105000	usd
CY2023Q2	us-gaap	Assets Assets	36783000	usd
CY2023Q2	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	5069000	usd
CY2023Q2	us-gaap	Operating Income Loss OperatingIncomeLoss	-1232000	usd
CY2023Q2	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1103000	usd
CY2023Q2	us-gaap	Depreciation And Amortization DepreciationAndAmortization	227000	usd
CY2023Q2	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	78000	usd
	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	11267000	usd
	us-gaap	Operating Income Loss OperatingIncomeLoss	-2526000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	307000	usd
	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-1142000	usd
	us-gaap	Depreciation And Amortization DepreciationAndAmortization	392000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	225000	usd
	us-gaap	Segment Expenditure Addition To Long Lived Assets SegmentExpenditureAdditionToLongLivedAssets	225000	usd

Files In Submission

Name	View Source	Status
cvv-20240630_cal.xml	Edgar Link	unprocessable
cvv-20240630_lab.xml	Edgar Link	unprocessable
0001493152-24-031585-index-headers.html	Edgar Link	pending
0001493152-24-031585-index.html	Edgar Link	pending
0001493152-24-031585.txt	Edgar Link	pending
0001493152-24-031585-xbrl.zip	Edgar Link	pending
cvv-20240630.xsd	Edgar Link	pending
ex31-1.htm	Edgar Link	pending
ex31-2.htm	Edgar Link	pending
ex32-1.htm	Edgar Link	pending
ex32-2.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
form10-q.htm	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
form10-q_htm.xml	Edgar Link	completed
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cvv-20240630_def.xml	Edgar Link	unprocessable
cvv-20240630_pre.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CVV
CVD EQUIPMENT CORP Stock $cvv

2024 Q3 Form 10-Q Financial Statement

#000149315224031585 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV CVD EQUIPMENT CORP Stock $cvv

2024 Q3 Form 10-Q Financial Statement

#000149315224031585 Filed on August 13, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CVV
CVD EQUIPMENT CORP Stock $cvv